Back to search

Article

Increase in antibody titers from H5N1 vaccine confers cross-protection against highly pathogenic H5N1 influenza virus

2024-12-12

Abstract excerpt

<title>Abstract</title> <p>H5N1 is a highly pathogenic avian influenza (HPAI) virus that has exhibited a significant capacity for adaptation and transmission among diverse mammalian species, thereby raising concerns regarding its pandemic potential. Vaccination constitutes a crucial strategy for controlling the spread of HPAI, rendering the development of effective vaccines and treatments for H5N1 a paramount pub...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd7bd504-0228-5cd6-a9c7-a5547a2c59f6
DOI
10.21203/rs.3.rs-5475107/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Increase in antibody titers from H5N1 vaccine confers cross-protection against highly pathogenic H5N1 influenza virusDOI 10.21203/rs.3.rs-5475107/v1
Sex differences in vaccine-induced neuraminidase cross-recognition and protection against H5N1 in miceSemantic proximity
A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A VirusSemantic proximity
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in HumansSemantic proximity
A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsSemantic proximity
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boostSemantic proximity
Assessment of cross-reactive neutralizing antibodies induction against H5N1 clade 2.3.4.4b by prior seasonal influenza immunization in retail workersSemantic proximity
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 VirusesSemantic proximity
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virusSemantic proximity
Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx VirusesSemantic proximity
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus ChallengeSemantic proximity
Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.Semantic proximity
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice.Semantic proximity
Select a neighboring publication to make it the new centre.